Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.37B | 1.72B | 1.67B | 1.69B | 1.64B | 1.76B | Gross Profit |
152.06M | 228.09M | 214.75M | 193.84M | 226.88M | 267.99M | EBIT |
36.65M | 53.27M | 62.36M | 53.50M | 31.05M | 90.96M | EBITDA |
81.59M | 73.96M | 75.21M | 62.94M | 77.88M | 144.83M | Net Income Common Stockholders |
25.09M | 39.47M | 38.39M | 34.24M | 48.54M | 98.68M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
114.81M | 107.31M | 147.46M | 121.48M | 185.19M | 264.34M | Total Assets |
822.96M | 802.77M | 790.65M | 718.33M | 777.53M | 785.03M | Total Debt |
7.95M | 8.03M | 36.23M | 33.10M | 11.30M | 11.36M | Net Debt |
-56.37M | -48.74M | -18.09M | 6.82M | -59.49M | -127.97M | Total Liabilities |
308.76M | 302.85M | 334.04M | 292.16M | 324.85M | 304.57M | Stockholders Equity |
514.20M | 499.93M | 456.62M | 426.17M | 452.68M | 480.46M |
Cash Flow | Free Cash Flow | ||||
71.07M | 24.47M | 38.09M | -13.38M | 31.42M | 212.87M | Operating Cash Flow |
76.42M | 30.80M | 43.50M | -8.17M | 37.11M | 217.21M | Investing Cash Flow |
-6.70M | 6.05M | -3.29M | 2.58M | -22.99M | -36.84M | Financing Cash Flow |
-41.09M | -31.05M | -12.15M | -38.93M | -82.65M | -68.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $1.61B | 15.10 | 11.19% | 2.33% | 19.16% | 31.92% | |
73 Outperform | $1.06B | 26.41 | 8.37% | ― | 3.71% | 1.32% | |
69 Neutral | $977.20M | 36.07 | 11.28% | ― | 30.04% | 43.47% | |
63 Neutral | $1.21B | ― | -10.01% | ― | -1.13% | -17.77% | |
54 Neutral | $5.37B | 3.35 | -45.10% | 2.79% | 16.77% | -0.01% | |
53 Neutral | $1.06B | 312.64 | 42.49% | ― | 9.05% | ― | |
45 Neutral | $843.03M | 18.62 | -21.08% | ― | -18.13% | -215.78% |
On May 27, 2025, Healthcare Services held its annual shareholder meeting to vote on various management proposals. The shareholders elected nine directors for one-year terms, approved the executive compensation in a non-binding advisory vote, and ratified Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (HCSG) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Healthcare Services stock, see the HCSG Stock Forecast page.